Executives On The Move: I-Mab Brings On An Amgen Communications Exec And SciTech Picks A CMO, Along With A Promotion At Urovant Sciences
Executive Summary
I-Mab Biopharma, a Chinese firm focusing on biologics for cancer and immune diseases, brings on an Amgen exec as global head, corporate communications, and SciTech Development, with its proprietary nano-delivery system, adds a new CMO. Plus, urologic therapies company Urovant Sciences promotes a director to CEO.